Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-007564

Director sold 7,500 shares at an average $176.05 ($1,320,380)

From the SEC's structured data for this filing

Trades in this filing

STUELPNAGEL JOHN R · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-01 Sale : show line 1 in the form −400 $174.14 $69,656 473,091 D
2021-02-01 Sale : show line 2 in the form −3,094 $175.38 $542,624 469,997 D
2021-02-01 Sale : show line 3 in the form −2,304 $176.14 $405,821 467,693 D
2021-02-01 Sale : show line 4 in the form −1,202 $177.23 $213,035 466,491 D
2021-02-01 Sale : show line 5 in the form −300 $178.16 $53,447 466,191 D
2021-02-01 Sale : show line 6 in the form −200 $178.98 $35,796 465,991 D
Open-market sales · 7,500 sh · avg $176.05 · $1,320,380
Loading xslF345X03/doc4.xml…